Objective Information on societal cost of patients with Borderline Personality Disorder (BPD)
and spouses is limited. The aim was to investigate factual societal costs before and after …

There has been considerable debate on the extent to which future costs should be included
in cost-effectiveness analyses of health technologies. In this article, we summarize the …

When healthcare interventions prolong life, people consume medical and non-medical
goods during the years of life they gain. It has been argued that the costs for medical …

Life‐saving medical technologies result in additional demand for health care due to
increased life expectancy. However, most economic evaluations do not include all medical …

Background Information on welfare cost of patients with schizophrenia and spouses is
limited. Aim The main aim of this study to investigate factual societal mean annual costs per …

The occurrence of future unrelated medical costs is a direct consequence of life-prolonging
interventions, but most pharmacoeconomic guidelines recommend the exclusion of these …

In this editorial, we consider the vexing issue of 'unrelated future costs'(for example, the
costs of caring for people with dementia or kidney failure after preventing their deaths from a …

Objectives This study aims to develop a catalog of annual age-and medical condition—
specific healthcare costs per capita among those who are living at a certain age (survivors) …

Objective To provide up-to-date and comprehensive US data tables to estimate future net
resource use, including nonlabor market production, and examine distributional impacts of …

Objective Information on societal cost of patients with schizotypal disorder is limited. The aim
was to investigate the societal costs of schizotypal disorder before and after initial diagnosis …